I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
How OCT Imaging Detects Wet AMD Early
Understanding Wet AMD
Wet AMD is a serious retinal condition that can move quickly and cause lasting harm. Knowing how it develops helps explain why early detection matters so much and why routine imaging is such a critical part of care.
The retina is the light-sensitive tissue lining the back of your eye. It processes the images you see and sends signals to your brain. The macula is the small central area of the retina responsible for sharp, detailed vision, the kind you rely on for reading, driving, and recognizing faces.
In wet AMD (wet age-related macular degeneration), abnormal, fragile blood vessels grow beneath the retina in a layer called the choroid. These vessels are unstable and prone to leaking fluid or blood into the macula. Even small amounts of leakage can damage the delicate cells you depend on for clear central vision.
One of the greatest challenges with wet AMD is that damage can begin long before you notice anything is wrong. Tiny amounts of fluid may leak from abnormal blood vessels and collect in or beneath the retina without immediately affecting what you see. By the time symptoms like blurry or distorted central vision become noticeable, meaningful damage may have already occurred.
This silent early phase is exactly why regular monitoring with advanced imaging is so important. Finding disease activity at its earliest stage gives treatment the best opportunity to preserve your vision before irreversible harm is done.
Dry AMD is the more common form of macular degeneration. It involves the gradual thinning of the macula and the buildup of small deposits called drusen beneath the retina. Dry AMD typically progresses slowly over years and causes gradual central vision changes.
Wet AMD is less common but far more aggressive. It can develop suddenly when abnormal blood vessels begin to grow and leak beneath the retina. Anyone with dry AMD can convert to wet AMD at any time, which is why ongoing monitoring is essential for all AMD patients, regardless of which form they currently have.
What OCT Imaging Is and How It Works
OCT is one of the most powerful diagnostic tools available in retina care today. It provides a level of detail that no other routine eye test can offer and can be performed quickly and comfortably at every visit.
OCT stands for optical coherence tomography. It is a non-invasive imaging test that uses safe infrared light beams to create highly detailed, cross-sectional pictures of the retina. The device sends light into the eye and measures how it reflects back from each layer of retinal tissue. A computer then assembles these measurements into precise images, similar to how an MRI creates layered images of the body, but using light waves instead of magnetic fields.
A standard eye examination or retinal photograph can only show the surface of the retina. OCT goes much deeper. It reveals all the individual layers of the retina in remarkable detail and can measure retinal thickness with a very high degree of precision.
This depth of detail is especially important for detecting wet AMD. Fluid hiding beneath the retinal surface is one of the earliest indicators of the disease. OCT shows this fluid as dark or swollen spaces between the normally compact retinal layers, even when the amount of fluid is far too small to cause any noticeable change in your vision.
An OCT scan is quick, comfortable, and requires no contact with your eye. You sit in front of the machine, rest your chin on a support, and look at a small target while the device scans your eye with a gentle beam of light. There are no flashes and no discomfort during the test itself.
Your pupils may be dilated with eye drops beforehand to allow a clearer view of the retina, but the scan is painless and takes only a few minutes. Results are available immediately for your retina specialist to review and discuss with you at the same visit.
Who Should Have OCT Screening for Wet AMD
Not everyone needs the same level of monitoring. Certain people face a significantly higher risk and benefit most from regular OCT imaging. Understanding your risk helps you and your retina specialist plan the right screening schedule together.
Several factors increase the likelihood of developing wet AMD. If any of the following apply to you, regular OCT screening is especially important:
- Age 65 or older, with risk increasing significantly after age 85
- A diagnosis of dry AMD, especially with large drusen or changes to the retinal pigment epithelium (the supportive cell layer beneath the retina)
- Advanced AMD already present in the other eye
- A family history of macular degeneration
- Current or past smoking, which is one of the most significant modifiable risk factors for AMD
- Female sex or white racial background, both of which are associated with higher prevalence of AMD
People who already have dry AMD are at particularly elevated risk of developing wet AMD. Research has shown that eyes with early, subclinical neovascularization (abnormal blood vessel growth beneath the retina that has not yet begun leaking or causing symptoms) have a substantially higher rate of converting to active wet AMD within a year compared to eyes without these early changes.
This makes OCT an especially important monitoring tool for anyone already living with a dry AMD diagnosis. Catching the conversion to wet AMD before vision is affected provides the most favorable conditions for treatment.
The appropriate frequency for OCT screening depends on your personal risk level and the findings at each visit. If you have been diagnosed with dry AMD, your retina specialist may recommend scans every few months to watch closely for early signs of conversion to wet AMD. If your overall risk is lower, an annual scan during a dilated eye exam may be appropriate.
Your retina specialist will determine the right schedule based on your imaging findings and your full clinical picture. This is an individual decision that should be revisited regularly as your situation may change over time.
How OCT Detects Wet AMD at Its Earliest Stage
The true value of OCT is its ability to find disease activity before you feel it. Understanding what the test looks for can help you appreciate why this level of monitoring matters so much for preserving your vision long term.
One of the first signs of wet AMD is the accumulation of fluid in or around the retina. OCT can detect fluid at three distinct locations: within the retinal layers themselves (intraretinal fluid), just beneath the retina (subretinal fluid), and beneath the retinal pigment epithelium (sub-RPE fluid). The presence of fluid at any of these levels suggests active wet AMD.
Because OCT is so sensitive, it can identify these changes weeks or even months before they cause any noticeable difference in your vision. This early warning gives your retina specialist the opportunity to begin treatment at the most effective moment, when the best outcomes are possible.
OCT can also reveal the formation of choroidal neovascular membranes, which is the medical term for the abnormal blood vessels responsible for wet AMD. On an OCT scan, these membranes appear as irregular thickening beneath the retina. Identifying these structures early, sometimes even before they have started to leak, allows your specialist to begin planning treatment proactively rather than reactively.
OCT is among the most accurate diagnostic tools available for detecting wet AMD, with very high sensitivity for identifying the fluid and structural changes that define the disease.
One of the most valuable features of OCT is its ability to compare images taken at different visits. Your retina specialist can place your current scan alongside previous ones to measure even tiny changes in retinal thickness or identify new areas of fluid accumulation that might not be apparent from a single scan alone.
These comparisons help determine whether the disease is stable, responding well to treatment, or beginning to worsen. They also guide important decisions about how frequently treatment is needed and whether the current medication is achieving the desired result.
What Happens After OCT Finds Signs of Wet AMD
Discovering signs of wet AMD on an OCT scan is not the end of the story. It is the beginning of a focused, organized response designed to protect as much of your vision as possible.
If your OCT reveals fluid or abnormal blood vessel growth, your retina specialist may order additional imaging to confirm the diagnosis and plan treatment. Fluorescein angiography is a test in which a special dye is injected into a vein in your arm. The dye travels to the blood vessels of the retina, where photographs are taken to show exactly where leakage is occurring. OCT angiography, a newer technique that maps blood flow through the retina without the use of dye, may also be used. Together, these tests provide a complete and detailed picture of the disease and its extent.
The primary treatment for wet AMD is anti-VEGF therapy. VEGF (vascular endothelial growth factor) is a protein that promotes the growth of abnormal blood vessels. Anti-VEGF medications work by blocking this protein, which reduces leakage from abnormal vessels and helps stabilize or, in some cases, improve vision. These medications are delivered directly into the eye through a procedure called an intravitreal injection, performed in the office using numbing drops to minimize discomfort.
Several anti-VEGF medications are currently approved and in use for wet AMD:
- Eylea (aflibercept), typically given every 4 to 8 weeks after an initial loading phase of monthly injections
- Eylea HD (high-dose aflibercept), given monthly for the first three months and then every 8 to 16 weeks in appropriate patients
- Lucentis (ranibizumab), the first anti-VEGF medication approved specifically for wet AMD, typically given monthly
- Avastin (bevacizumab), FDA-approved for cancer and widely used off-label for wet AMD, typically every 4 to 6 weeks
- Vabysmo (faricimab), a bispecific antibody that targets two pathways involved in abnormal vessel growth, with dosing as infrequently as every 16 weeks in appropriate patients
Treatment decisions are always individualized. Your retina specialist will recommend the medication and dosing schedule that best fits your specific situation and imaging findings.
After treatment begins, OCT becomes the primary tool for tracking how well the medication is working. Your retina specialist will perform OCT scans at each visit to assess whether fluid has decreased, remained stable, or returned.
Many retina specialists use an approach called treat-and-extend. In this strategy, the interval between injections is gradually lengthened as long as your wet AMD remains under control on OCT. This helps find the longest safe interval between treatments while keeping the disease stable, reducing the overall treatment burden without compromising the quality of your care.
Advances in AMD Monitoring and Treatment
Retina care continues to advance at a meaningful pace. New monitoring approaches and emerging therapies are expanding what is possible for patients managing AMD at every stage of the disease.
One of the most promising recent developments in retina care is the concept of home OCT monitoring for patients with wet AMD. Systems designed to allow patients to perform daily self-imaging at home have been under evaluation. Scans taken on these devices can be transmitted and analyzed using artificial intelligence algorithms, potentially allowing earlier detection of disease reactivation between office visits.
The availability and regulatory status of home monitoring tools continues to evolve. Your retina specialist can advise whether home monitoring is appropriate for your specific situation and whether it is currently available.
Anti-VEGF therapy remains the established standard of care for wet AMD. At the same time, the treatment landscape for all forms of AMD is advancing. Medications that target additional biological pathways involved in retinal disease have made it possible for some patients to extend the time between treatments while maintaining control of the disease.
Clinical research continues to explore new therapeutic options for AMD, including participation in carefully monitored trials at specialized retina centers. This ongoing work holds genuine promise for improving outcomes for patients living with all forms of macular degeneration.
Living with a Wet AMD Diagnosis
A diagnosis of wet AMD calls for ongoing attention and active participation in your care. There are meaningful steps you can take at home alongside your professional treatment plan.
An Amsler grid is a simple, practical tool for checking your central vision between office visits. The grid looks like graph paper with a dot in the center. By covering one eye at a time and focusing on the dot, you can check whether any lines appear wavy, whether any area looks blurry or missing, or whether a dark spot has appeared in the center of your field of vision.
If you notice any of these changes, contact your retina specialist promptly rather than waiting for your next scheduled appointment. Home monitoring with an Amsler grid does not replace OCT imaging, but it serves as an important supplement that can alert you to changes that deserve timely attention.
Certain lifestyle choices may help support your overall retinal health and potentially reduce the risk of AMD progression. Your retina specialist may recommend the following:
- Not smoking, as smoking is one of the most significant factors in AMD risk and progression
- Eating a diet rich in leafy green vegetables, fish, and colorful fruits and vegetables
- Staying physically active and maintaining a healthy weight
- Wearing sunglasses that block ultraviolet light when outdoors
- Taking AREDS2 nutritional supplements if your retina specialist recommends them based on your stage of AMD
A wet AMD diagnosis can feel frightening, and it is completely understandable to have concerns about what it means for your daily life and independence. Many patients find it helpful to connect with low-vision rehabilitation services, patient support organizations, or counseling to work through the emotional side of managing a chronic eye condition.
Your retina specialist and care team can connect you with resources to help you adapt to any vision changes and maintain your quality of life. You do not have to navigate this diagnosis on your own, and meaningful support is available throughout your care.
When to See a Retina Specialist
Knowing when to seek care, and how urgently, is essential for protecting your vision. Some situations require same-day evaluation and should not be delayed.
If you experience any of the following, contact a retina specialist or seek emergency eye care right away rather than waiting for a scheduled appointment:
- A sudden increase in floaters (dark spots, strings, or shadows drifting through your vision)
- New flashes of light in your visual field
- A curtain, shadow, or veil appearing across any part of your vision
- Sudden loss of vision in one eye
- New distortion, especially straight lines appearing wavy or bent
- A dark or blank spot appearing in the center of your vision
These symptoms can indicate serious retinal problems that require prompt evaluation. The sooner a retinal emergency is assessed and treated, the better the chance of preserving vision.
Even without any symptoms, regular eye exams that include OCT imaging are essential if you have risk factors for wet AMD. An optometrist or general ophthalmologist can screen for early signs of AMD and refer you to a retina specialist if anything requires further evaluation.
If you are over 65, have a family history of AMD, or have been diagnosed with dry AMD in one or both eyes, ask your eye care provider about incorporating OCT into your regular visits. Early detection through routine OCT imaging remains one of the most effective ways to protect your central vision over time.
Frequently Asked Questions
Here are answers to questions we frequently hear from patients about OCT imaging and wet AMD. These are meant to add practical guidance to help you make informed decisions about your care.
Yes, and this is one of the most important advantages OCT offers. The test can identify tiny amounts of fluid beneath the retinal layers or early abnormal blood vessel activity long before these changes cause any visible difference in your day-to-day sight. For people at elevated risk, including those with existing dry AMD or a strong family history, regular OCT is the most reliable way to catch wet AMD during the window when treatment is most effective. Waiting for symptoms to appear before seeking evaluation can allow preventable damage to occur.
OCT and fluorescein angiography each provide a different type of information that complements the other. OCT uses light to create detailed structural images of the retinal layers and can detect fluid or early blood vessel changes without any dye or injection. Fluorescein angiography uses a dye injected into a vein to photograph blood flow in the retina and identify exactly where active leakage is occurring. When OCT reveals a concern, fluorescein angiography is often used to confirm the finding and map the location of leaking vessels in preparation for treatment. Both tests may be needed together for a complete diagnostic picture.
When OCT reveals active fluid from abnormal blood vessels, prompt treatment is generally recommended. Wet AMD can cause meaningful vision loss in a relatively short period if left untreated, so there is real value in acting quickly. Treatment typically begins with a series of monthly anti-VEGF injections during an initial loading phase lasting several months. Starting at this early stage, before significant central vision has already been lost, provides the best opportunity to maintain your current level of sight. Your retina specialist will review your findings with you and recommend a personalized plan.
Yes. OCT uses infrared light, not radiation, and involves no physical contact with your eye. There is no known limit to how often the scan can be safely performed, and there are no side effects associated with repeated use. During active treatment, OCT is typically performed at every visit to closely track your response to medication. Even with very frequent scanning over many years, there is no evidence that OCT poses any risk to eye health.
Yes. Wet AMD can reactivate after a period of stability, sometimes without obvious warning signs. This is why ongoing OCT monitoring is recommended even when the disease appears well-controlled. Over time, if stability is maintained, your retina specialist may gradually extend the interval between visits and scans. However, stopping monitoring entirely is generally not recommended, because identifying any reactivation early gives the best chance of preventing additional vision loss before it becomes permanent.
If your optometrist or general ophthalmologist sees signs of AMD during a routine examination, a referral to a retina specialist is the appropriate and important next step. This referral should be acted on promptly rather than delayed. A retina specialist will perform OCT and any other imaging needed to determine whether wet AMD is present and whether treatment should begin. AMD referrals are worth treating with a sense of urgency, as the window for preventing vision loss can be narrow once active disease is underway.
Take the Next Step in Protecting Your Vision
At New England Retina Associates, our fellowship-trained vitreoretinal surgeons are dedicated to providing expert, compassionate care for patients with AMD and other serious retinal conditions throughout Connecticut. Whether you have been referred by your eye doctor, are newly diagnosed, or have concerns about your risk, we welcome the opportunity to work with you. Early detection through OCT and timely treatment remain the most powerful tools we have for protecting your central vision, and we are here to support you at every step of your care.
30 Years of Care & Commitment
